Autopsy report · NCT01028781

Open Label of Thalidomide in Treatment of Women With Chronic Pelvic Pain Associated With Endometriosis

“Difficulty finding eligible participants and lack of funding.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 years 2 months after it had already started.
• Ran for about 2 years 10 months before it stopped.
• 9 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

University of North Carolina, Chapel Hill

Sponsor type

University, hospital or other

Conditions

Endometriosis

Interventions

Thalidomide

Participants

9

Sites

1

Countries

United States

Trials that died the same way

• Phase I Nicotinic Agonist Treatment Trial for Autism
  “difficult to find participants and no funding” (87% match in meaning)
• Androxal in Male Infertility
  “Difficult eligibility and lack of funding” (83% match in meaning)
• Implementation of STTR Strategies Among People Who Inject Drugs in Malaysia
  “lack of eligible participants” (80% match in meaning)
• Project 1: ACHIEVE- HTN
  “Due lack of eligible participants” (77% match in meaning)
• Quality of Life in Patients With Multiple Myeloma-validation Study
  “Not enough participants and study funding” (75% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.